Resumo

RIOS-GARCES, Roberto; ESPINOSA, Gerard; VOLLENHOVEN, Ronald van  e  CERVERA, Ricard. Treat to target in systemic lupus erythematosus. Rev.Colomb.Reumatol. [online]. 2021, vol.28, suppl.1, pp.101-106.  Epub 18-Fev-2022. ISSN 0121-8123.  https://doi.org/10.1016/j.rcreu.2021.05.002.

Systemic lupus erythematosus (SLE) is the most representative disorder within systemic autoimmune diseases. The treat-to-target strategy in SLE was established half a decade ago and, since then, remarkable advances have been made. An international consensus has defined and unified the term remission and also low disease activity has been proposed as an alternative and, perhaps, more realistic target. Both of them have proven to be meaningful in terms of improving several outcomes, and have opened the path for future research in clinical trials.

Palavras-chave : Systemic lupus erythematosus; Treat-to-target; Remission; Lupus low disease activity.

        · resumo em Espanhol     · texto em Inglês     · Inglês ( pdf )